Next Generation Pharmaceutical Impactor: A new impactor for pharmaceutical inhaler testing. Part III. Extension of archival calibration to 15 L/min

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 17, Issue 4, 2004, Pages 335-343

  Marple, Virgil A ^a   Olson, Bernard A ^a   Santhanakrishnan, Kumaragovindhan ^a   Roberts, Daryl L ^b   Mitchell, Jolyon P ^c   Hudson Curtis, Buffy L ^d  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MSP Corporation   (United States)

^c TRUDELL MEDICAL INTERNATIONAL   (Canada)

^d GLAXOSMITHKLINE   (United States)

Author keywords

Calibration; Cascade impactor; Inhaler testing; Nebulizer testing; Next generation pharmaceutical impactor

Indexed keywords

OLEIC ACID;

AEROSOL; ARTICLE; CALIBRATION; DEVICE; DRUG DELIVERY SYSTEM; DYNAMICS; FILTER; FLOW RATE; GRAVITY; INHALER; INTERNATIONAL STANDARD UNIT; MEASUREMENT; NEBULIZER; NEXT GENERATION PHARMACEUTICAL IMPACTOR; PARTICLE SIZE;

ADMINISTRATION, INHALATION; AEROSOLS; CALIBRATION; EQUIPMENT DESIGN; HUMANS; METERED DOSE INHALERS; NEBULIZERS AND VAPORIZERS; PARTICLE SIZE; TECHNOLOGY, PHARMACEUTICAL;

EID: 12244300136     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/jam.2004.17.335     Document Type: Article

References (17)

1. USP 26-NF 21. 2003. Chapter 601 - physical tests and determinations: aerosols. United States Pharmacopeia. Rockville, MD. 2105-2123.
2. rd ed. Suppl. 2001. Council of Europe, 67075 Strasbourg, France. 113-124.
3. Marple, V.A., D.L. Roberts, F.J. Romay, et al. 2003. Next generation pharmaceutical impactor. Part 1: Design. J. Aerosol Med. 16:283-299.
4. Marple, V.A., B.A. Olson, K. Santhanakrishnan, et al. 2003. Next generation pharmaceutical impactor. Part II: Calibration. J. Aerosol Med. 16:301-324.
5. Comité Européen de Normalisation. 2001. Respiratory therapy equipment. Part 1: Nebulizing systems and their components. prEN 13544-1. CEN Brussels, Belgium, 33-38.
6. Jauernig, J., M. Hug, M. Knoch, et al. 2002. Contribution to the aerodynamic particle size assessment of nebulized drugs using the next generation impactor (NGI). In Drug Delivery to the Lungs - XIII. Aerosol Society, London, 44-47.
7. Hinds, W.C. 1999. Properties, Behavior, and Measurement of Airborne Particles, 2nd ed. Wiley-Interscience, New York.
8. Berglund, R.N., and B.Y.H. Liu. 1973. Generation of monodisperse aerosol standards. Environ. Sci. Technol. 7:147-153.
9. Marple, V.A. 1970 A Fundamental study of inertial impactors [Doctoral dissertation]. University of Minnesota, Minneapolis.
10. Marple, V.A., and B.Y.H. Liu. 1974. Characteristics of laminar jet impactors. Environ. Sci. Technol. 8:648-654.
11. Rader, D.J., and V.A. Marple. 1985. Effect of ultra-Stokesian drag and particle interception on impaction characteristics. Aerosol Sci. Technol. 4:141-156.
12. Rader, D.J., and V.A. Marple. 1984. Effect of particle gravitational forces on the calculation of impactor efficiency curves. In B.Y.H. Liu, D.Y.H. Pui, and H.J. Fission, eds. Aerosols: Science, Technology and Industrial Application of Air borne Particles. Elsevier, New York, 123-126.
13. Jauernig, J., S. Ohl., M. Luber, et al. 2003. Differences in results obtained with the Next Generation Impactor (NGI) for Pulmicort® suspension and according to the CEN-standard EN-13544-1 for a NaF-solution. In Drug Delivery to the Lungs XIV. Aerosol Society, London, 41-44.
14. Jauernig, J., S. Ohl, M. Luber, et al. 2004. Effects of the test set-up, formulation, and nebulizer type on aerodynamic droplet characteristics. In R.N. Dalby, P.R. Byron, J. Peart, et al., eds. Respiratory Drug Delivery IX, Davis Healthcare International Publishing, River Grove, IL, 609-612.
15. Berg, E., and L. Asking. 2004. Nebulizer droplet size distribution - refrigerated NGI at 15 L/min. In R.N. Dalby, P.R. Byron, J. Peart, et al., eds. Respiratory Drug Delivery IX, Davis Healthcare International Publishing, River Grove, IL, 361-363.
16. Finlay, W.H., and K.W. Stapleton. 1999. Undersizing of droplets from a vented nebulizer caused by aerosol heating during transit through an Andersen impactor. J. Aerosol Sci. 30:105-109.
17. Marple, V., D. Roberts, and J. Mitchell. 2004. A proposal for the use of the next generation pharmaceutical impactor (NGI) at flow rates between 15 and 30 L/min. In R.N. Dalby, P.R. Byron, J. Peart, et al., eds. Respiratory Drug Delivery IX. Davis Healthcare International Publishing, River Grove, IL, 701-703.